Post-earnings recap
Reported
Thu, Feb 1, 2024
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Quest Diagnostics reported an EPS of $2.15, slightly beating expectations. However, the stock reacted negatively, declining by 0.98%. The lack of revenue data and guidance may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.15 | N/A | +0.42% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.